Paul Andrew Moore

Insider Reports History

Location: 114 East 4 Th Avenue, Suite 800, Vancouver, British Columbia, Canada
Signature: /s/ Daniel Dex, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Andrew Moore:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Zymeworks Inc.	Chief Scientific Officer	Restricted Stock Unit	53K	$791K	$14.92	Jan 10, 2025	Direct
Zymeworks Inc.	Chief Scientific Officer	Common Stock	23.3K	$348K	$14.92	Jan 6, 2025	Direct
Zymeworks Inc.	Chief Scientific Officer	Stock Option (Right to Buy)	200K			Jul 18, 2022	Direct
Zymeworks Inc.	Chief Scientific Officer	Stock Option (Right to Buy)	79K			Jan 10, 2025	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Paul Andrew Moore

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ZYME	Zymeworks Inc.	Jan 10, 2025	2	$0	4	Jan 10, 2025	Chief Scientific Officer
ZYME	Zymeworks Inc.	Jan 6, 2025	6	-$316K	4	Jan 6, 2025	Chief Scientific Officer
ZYME	Zymeworks Inc.	Jan 5, 2024	6	-$106K	4	Jan 8, 2024	Chief Scientific Officer
ZYME	Zymeworks Inc.	Jan 5, 2023	2	$0	4	Jan 6, 2023	Chief Scientific Officer
ZYME	Zymeworks Inc.	Jul 18, 2022	1	$0	4	Jul 19, 2022	Chief Scientific Officer
ZYME	Zymeworks Inc.	Jul 18, 2022	0	$0	3	Jul 19, 2022	Chief Scientific Officer